---
schema_version: "secwatch.filing_event.v1"
accession: "0001654954-22-002090"
form_type: "8-K"
ticker: "ZIVO"
cik: "0001101026"
company_name: "Zivo Bioscience, Inc."
filed_at: "2022-02-25T23:59:59+00:00"
generated_at: "2026-06-27T04:01:50.780590+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "medium"
source: SEC EDGAR
---

# Zivo Bioscience terminates CEO Andrew Dahl for cause; Dahl resigns from board

## Summary
- CEO Andrew A. Dahl terminated for cause on Jan 4, 2022 after declining to resign; no separation agreement reached.
- On Feb 18, 2022, Dahl resigned from the board of directors; board size reduced to four members.
- Principal executive office moved to 21 E. Long Lake Road, Suite 100, Bloomfield Hills, MI effective Feb 21, 2022.

## SEC filing metadata
- accession: 0001654954-22-002090
- form_type: 8-K
- ticker: ZIVO
- cik: 0001101026
- company_name: Zivo Bioscience, Inc.
- filed_at: 2022-02-25T23:59:59+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: medium
- sec_items: 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1101026/000165495422002090/0001654954-22-002090-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1101026/000165495422002090/zivo_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001654954-22-002090
- JSON: https://secwatch.observer/filing/0001654954-22-002090.json
- Plain text: https://secwatch.observer/filing/0001654954-22-002090.txt

## Key facts
- Executive change
  Andrew A. Dahl resigned as member of the board of directors at Zivo Bioscience, Inc..
  - Action: resigned
  - Role: member of the board of directors
  source text: on February 18, 2022, Mr. Dahl resigned from his position as a member of the Company’s board of directors.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1101026/000165495422002090/0001654954-22-002090-index.htm
- Executive change
  Andrew A. Dahl was terminated as President and Chief Executive Officer at Zivo Bioscience, Inc..
  - Action: terminated
  - Role: President and Chief Executive Officer
  source text: the Company terminated the employment of Andrew A. Dahl, the President and Chief Executive Officer of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1101026/000165495422002090/0001654954-22-002090-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.